New Key Statistics Module, Z-Score and F-Score
GREY:TKUNF Key Ratios
| Market Cap $ M | 7.04 |
| Enterprise Value $ M | 10.64 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.71 |
| Price/Sales | 0.51 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 11.00 |
| EPS (TTM) $ | -0.38 |
| Beneish M-Score | -5.89 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -697.70 |
| EV-to-EBIT | -0.46 |
| EV-to-EBITDA | -1.29 |
| PEG | -- |
| Shares Outstanding M | 80.92 |
| Net Margin (%) | -200.97 |
| Operating Margin % | -64.38 |
| Pre-tax Margin (%) | -212.52 |
| Quick Ratio | 0.50 |
| Current Ratio | 0.85 |
| ROA % (ttm) | -80.71 |
| ROE % (ttm) | -120.92 |
| ROIC % (ttm) | -28.12 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.42 |
TKUNF Number of Guru Trades
TKUNF Volume of Guru Trades
Gurus Latest Trades with GREY:TKUNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
GREY:TKUNF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Tikun Olam Cannbit Pharmaceuticals Ltd Insider Transactions
No Available Data
News about GREY:TKUNF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers